Accelerated Clinical Research in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Accelerated Clinical Research in Mexico

Accelerated Clinical Research in Mexico – Human Trials in LATAM

In recent years, Mexico has emerged as a significant player in the field of clinical research, offering a unique environment that promotes accelerated development and innovation. With its robust healthcare infrastructure, diverse patient population, and supportive regulatory framework, Mexico has become an attractive destination for conducting clinical trials.

This blog explores the key factors that make Mexico an ideal hub for accelerated clinical research and the potential benefits it offers to both researchers and patients.

Healthcare Infrastructure and Access to Diverse Patient Population

Mexico boasts a well-established healthcare infrastructure, including a network of prestigious hospitals, research institutions, and highly skilled medical professionals. This infrastructure enables researchers to conduct clinical trials in state-of-the-art facilities, ensuring high-quality data collection and analysis.

Furthermore, Mexico’s population is ethnically diverse, encompassing a broad range of genetic profiles. This diversity presents a significant advantage for clinical research, as it allows for the recruitment of a more representative patient cohort, ultimately leading to more robust and generalizable results. This diversity is particularly valuable in pharmacogenetic studies, where the response to drugs can vary among different ethnic groups.

Regulatory Framework and Expedited Approval Process

Mexico’s regulatory environment has been streamlined and strengthened to facilitate efficient clinical research. The Federal Commission for Protection against Health Risks (COFEPRIS) is the regulatory body responsible for overseeing clinical trials and ensuring patient safety. COFEPRIS has implemented measures to expedite the approval process for clinical trials, reducing bureaucratic hurdles and enabling researchers to initiate studies more rapidly.

In addition, Mexico’s regulatory framework aligns with international standards, such as Good Clinical Practice (GCP) guidelines, ensuring that data generated from clinical trials in Mexico is globally accepted. This harmonization facilitates multinational trials and attracts collaborations with pharmaceutical companies and research organizations.

Accelerated Clinical Research in Mexico

Accelerated Clinical Research in Mexico

Accelerated Clinical Research in Mexico

Cost-Effectiveness and Competitive Advantage

Mexico offers a cost-effective environment for conducting clinical research without compromising quality. Compared to other countries, the cost of conducting clinical trials in Mexico is significantly lower, making it an attractive option for researchers and sponsors. The reduced costs can be attributed to factors such as lower labor costs, affordable medical supplies, and lower administrative expenses.

Moreover, Mexico’s geographical proximity to the United States allows for efficient cross-border collaborations and easy access to a vast market for pharmaceutical products. This advantage further enhances Mexico’s appeal as a destination for clinical research.

Ethical Considerations and Patient-Centric Approach

Mexico places a strong emphasis on patient rights and welfare, ensuring ethical standards are upheld throughout the clinical research process. Institutional Review Boards (IRBs) rigorously review study protocols to protect the rights and well-being of study participants.

Additionally, Mexico’s patient-centric approach promotes inclusivity and access to innovative treatments. Clinical trials offer patients in Mexico access to cutting-edge therapies that may not otherwise be available to them. This not only benefits the participants directly but also contributes to advancing medical knowledge and improving healthcare outcomes for future patients.

Collaboration Opportunities and Research Networks

Mexico’s commitment to advancing clinical research is evident through its establishment of research networks and collaborative initiatives. These networks foster collaboration between academic institutions, hospitals, and industry partners, promoting knowledge exchange and resource sharing. Such collaborations enhance the expertise and capabilities available to researchers, leading to more robust study designs and comprehensive data analysis.


Mexico’s accelerated clinical research landscape provides an ideal environment for researchers and sponsors to conduct innovative studies and drive medical advancements. The country’s robust healthcare infrastructure, diverse patient population, streamlined regulatory framework, cost-effectiveness, and ethical considerations collectively position Mexico as an attractive destination for clinical research.

By leveraging these advantages, researchers can expedite the development of novel therapies, contribute to global scientific knowledge, and ultimately improve patient care. As Mexico continues to strengthen its position in the field of clinical research, the potential for transformative medical breakthroughs grows exponentially.

Accelerated Clinical Research in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Accelerated Clinical Research in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Accelerated Clinical Research in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Accelerated Clinical Research in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Accelerated Clinical Research in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Accelerated Clinical Research in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Accelerated Clinical Research in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Accelerated Clinical Research in Mexico

The Cohortias Team

Accelerated Clinical Research in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Accelerated Clinical Research in Mexico

Network & Partnerships